18F-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axis.
Jiang Y, Zeng Q, Jiang Q, Peng X, Gao J, Wan H, Wang L, Gao Y, Zhou X, Lin D, Feng H, Liang S, Zhou H, Ding J, Ai J, Huang R.
Jiang Y, et al. Among authors: jiang q.
Theranostics. 2022 Aug 29;12(14):6395-6408. doi: 10.7150/thno.74848. eCollection 2022.
Theranostics. 2022.
PMID: 36168616
Free PMC article.